Literature DB >> 1141453

Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells.

A B Kay, J M McVie, A E Stuart, A Krajewski, L W Turnbull.   

Abstract

Cultured lymph node cell supernatants from five out of six cases of Hodgkin's disease were relatively more chemotactic for peripheral blood eosinophils than neutrophils. In contrast, supernatants from two cases of lymphocytic lymphoma and four nodes showing reactive hyperplasia were chemotactic for neutrophils but had little eosinophil chemotactic activity. In most instances the dgree of eosinophil infiltration observed histologically in the Hodgkin's lymph node correlated with elaboration of eosinophil chemotactic activity from the cultured cells. Following gel-filtration of three of the Hodgkin's lymphnode supernatants, four peaks of eosinophil chemotactic activity were demonstrated in each case. One of these corresponded in molecular size to th previously described eosinophil chemotactic factor of anaphylaxis (ECF-A). It is suggested that the eosinophil chemotactic activity of cultured lymph node cell supernatants may be on value in the diagnosis and classification of Hodgkin's disease.

Entities:  

Mesh:

Year:  1975        PMID: 1141453      PMCID: PMC475752          DOI: 10.1136/jcp.28.6.502

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

Review 1.  Biology of malignant neoplasia of the lymphoreticular tissues.

Authors:  R F Dorfman
Journal:  J Reticuloendothel Soc       Date:  1972-09

2.  Immunological aspects of reticulum cell neoplasia.

Authors:  A E Stuart
Journal:  Br Med J       Date:  1970-11-14

3.  Nature of Hodgkin's disease agent.

Authors:  N J Vianna; P Greenwald; J N Davies
Journal:  Lancet       Date:  1971-04-10       Impact factor: 79.321

4.  The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.

Authors:  A B Kay; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

5.  Tumor-associated eosinophilotactic factor.

Authors:  S I Wasserman; E J Goetzl; L Ellman; K F Austen
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

6.  A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes.

Authors:  L C Altman; R Snyderman; J J Oppenheim; S E Mergenhagen
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

7.  Hodgkin's disease: one entity or two?

Authors:  D W Smithers
Journal:  Lancet       Date:  1970-12-19       Impact factor: 79.321

8.  Hodgkin's disease. I.

Authors:  D W Smithers
Journal:  Br Med J       Date:  1967-04-29

9.  The pathology and nomenclature of Hodgkin's disease.

Authors:  R J Lukes; J J Butler
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

10.  An eosinophil leukocyte chemotactic factor of anaphylaxis.

Authors:  A B Kay; D J Stechschulte; K F Austen
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

View more
  9 in total

1.  Frequency distribution of tissue mast cells and eosinophilic granulocytes in tumor-draining axillary and paracolic lymph nodes.

Authors:  H P Horny; H A Horst
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 2.  Hodgkin's disease and anergy.

Authors:  T A Shiftan; J Mendelsohn
Journal:  Blut       Date:  1979-01-22

Review 3.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

Review 4.  Modulation of human eosinophil polymorphonuclear leukocyte migration and function.

Authors:  E J Goetzl
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

Review 5.  The human eosinophil: roles in host defense and tissue injury.

Authors:  P F Weller; E J Goetzl
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

6.  A novel eosinophil chemotactic factor derived from a histiocytic lymphoma of the central nervous system.

Authors:  E J Goetzl; J Rothenberg; E L Weber; C M Sinn; K F Austen
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

7.  Eosinophil predominance in Hodgkin's disease.

Authors:  J Tóth; O Dworák; J Sugár
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20

8.  The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration.

Authors:  A A Wadee; R Sher
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

Review 9.  Tumour-associated eosinophilia: a review.

Authors:  D Lowe; J Jorizzo; M S Hutt
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.